This advisory introduces readers to digital therapeutics (DTx) and the benefits of their use in behavioral health. It describes the research, regulatory, and reimbursement implications for DTx as well as selection and implementation considerations.
Dashboard: Filter Bricks
Main page content
Displaying results 1 - 2 of 2
Publication ID: PEP23-06-00-001
Published:
Publication ID: SMA15-4925
Published:
This advisory defines attention deficit hyperactivity disorder in adults, and explains interactions with substance use disorders.